Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Low blood sugar: spotting it and treating it

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Low blood sugar is the main safety issue in diabetes treatment, and it is also the one most often left out of the conversation at diagnosis.

Most people with type 2 diabetes will never have a serious episode. The ones at risk are a specific, identifiable group, and they need this information before they need it.

Related pages: Type 2 diabetes

The bottom line

What we know
  • Low blood sugar is defined as below 70 mg/dL; below 54 is clinically significant.
  • Metformin, GLP-1 agonists, SGLT2 inhibitors and DPP-4 inhibitors do not cause it on their own.
  • Insulin and sulfonylureas can cause it, including severe episodes.
  • The rule of 15 is the standard treatment for a conscious person.
  • Someone who cannot swallow safely must not be given food or drink; they need glucagon or emergency help.
What is still open
  • How often mild hypoglycemia goes unreported in type 2 diabetes.
  • The long-term consequences of repeated mild lows.
  • How best to restore awareness once it has been lost.

The story, step by step

  1. 1. Who is at risk ()
  2. 2. The signs ()
  3. 3. The treatment ()
  4. 4. Severe lows ()
  5. 5. Preventing it ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

It depends on the medicine

Review of many studies

What happens

Two classes do most of it.

What the research shows

  • Insulin of any kind can cause low blood sugar.
  • Sulfonylureas, such as glipizide, glyburide and gliclazide, push out insulin whether or not glucose is high, so they can too. Glyburide carries the highest risk, especially in older adults.
  • Meglitinides, taken with meals, carry a smaller but real risk.
  • Metformin, GLP-1 agonists, SGLT2 inhibitors, DPP-4 inhibitors and pioglitazone do not cause low blood sugar on their own, though they can contribute when combined with insulin or a sulfonylurea.
  • Risk rises with missed or delayed meals, more activity than usual, alcohol, kidney or liver impairment, older age, and recent weight loss that has made the previous dose too large.
  • Anyone starting insulin or a sulfonylurea should be told about this at the time of the prescription, not later.

Why it matters

If a person is on neither insulin nor a sulfonylurea, the risk is very low. That reassurance is worth stating plainly, because fear of lows stops some people taking medicines that cannot cause them.

What's still uncertain

  • How often sulfonylurea hypoglycemia leads to hospital attendance.
  • Whether sulfonylureas should be avoided entirely in older adults.

Read more

Next: The signs

Part 2 of 5

What it feels like

Review of many studies

What happens

Adrenaline first, then the brain.

What the research shows

  • Early signs come from adrenaline: shakiness, sweating, a racing heart, hunger, anxiety, tingling lips, pallor.
  • As glucose falls further the brain is affected: difficulty concentrating, confusion, slurred speech, blurred vision, irritability or unusual behaviour, drowsiness.
  • Severe hypoglycemia means a person needs someone else's help. It can cause seizures or loss of consciousness.
  • Lows during sleep may show only as night sweats, vivid dreams, a headache on waking or unusually high morning readings.
  • Repeated lows blunt the warning signs, a state called hypoglycemia unawareness, which is dangerous because the first symptom becomes confusion.
  • Symptoms can also appear at normal glucose levels in someone whose readings have been running very high for a long time. That is unpleasant but not dangerous, and it settles.

Why it matters

Knowing the early signs is what keeps an episode mild. Losing them is a reason to loosen targets deliberately for a while.

What's still uncertain

  • How quickly awareness can be restored by avoiding lows.
  • How to detect nocturnal hypoglycemia without continuous monitoring.

Read more

Next: The treatment

Part 3 of 5

The rule of 15

Review of many studies

What happens

Fifteen grams, fifteen minutes, recheck.

What the research shows

  • If the person is awake and can swallow safely, give about 15 grams of fast-acting carbohydrate.
  • Examples: four glucose tablets, a small tube of glucose gel, half a cup of juice or regular soda, a tablespoon of sugar or honey.
  • Wait 15 minutes and recheck. If still below 70 mg/dL, repeat the 15 grams.
  • Once recovered, eat a meal or a snack containing protein and longer-acting carbohydrate if the next meal is more than an hour away.
  • Chocolate, biscuits and ice cream are poor choices for treatment, because fat slows absorption of the sugar.
  • Lows caused by long-acting sulfonylureas or long-acting insulin can recur hours later, so one recovery is not necessarily the end of it.

Why it matters

Overtreating a low is the most common mistake, and it produces a high afterwards that gets blamed on something else. Fifteen grams, then wait, is the whole technique.

What's still uncertain

  • Whether glucose tablets are meaningfully better than other sources in practice.
  • The optimal follow-up snack.

Read more

Next: Severe lows

Part 4 of 5

When someone cannot help themselves

Review of many studies

What happens

Do not put anything in their mouth.

What the research shows

  • If a person is confused, unable to swallow safely, having a seizure or unconscious, do not give food or drink. They can choke.
  • Glucagon is the treatment. It is available as an injection and as a nasal powder, and a family member or colleague can be taught to give it.
  • Anyone at meaningful risk of severe lows should have glucagon prescribed and the people around them shown how to use it.
  • After giving glucagon, turn the person on their side, because vomiting is common, and call emergency services.
  • Call 911 if there is no glucagon, if the person does not recover within about 15 minutes, or if there has been a seizure.
  • Every severe episode should prompt a review of the treatment regimen, not just a discussion of what the person ate.

Why it matters

Glucagon is widely under-prescribed in type 2 diabetes. The people who need it are those on insulin or sulfonylureas who live alone or have lost their warning signs.

What's still uncertain

  • How to increase glucagon prescribing where it is indicated.
  • Whether nasal glucagon improves real-world use by bystanders.

Read more

Next: Preventing it

Part 5 of 5

What actually stops repeats

Review of many studies

What happens

Usually the dose, not the diet.

What the research shows

  • Report every low to the clinician, including the mild ones. They are the signal that a dose needs changing.
  • A pattern of lows at the same time of day points to a specific dose or a specific meal gap, and is the easiest kind to fix.
  • After substantial weight loss or an increase in activity, insulin and sulfonylurea doses often need reducing. This is a common cause of new lows in someone doing well.
  • Alcohol suppresses the liver's glucose release for hours, so lows can occur overnight after drinking. Eating carbohydrate alongside alcohol reduces this.
  • Check before driving if on insulin or a sulfonylurea, and do not drive below 70 mg/dL. Keep fast-acting glucose in the vehicle.
  • During illness, do not simply stop all medicines. Some are held and others continued, so ask for sick-day rules in advance and write them down.

Why it matters

Recurrent lows are a treatment problem with a treatment solution. Nobody should be adjusting their life around a dose that is simply too large.

What's still uncertain

  • How best to deliver sick-day guidance so it is available when needed.
  • Driving rules that balance safety against independence.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.